BioHarvest Sciences (NASDAQ:BHST) and Betterware de Mexico SAPI de C (NYSE:BWMX) Financial Contrast

BioHarvest Sciences (NASDAQ:BHST – Get Free Report) and Betterware de Mexico SAPI de C (NYSE:BWMX – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends and earnings.

Institutional & Insider Ownership

12.7% of Betterware de Mexico SAPI de C shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares BioHarvest Sciences and Betterware de Mexico SAPI de C”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BioHarvest Sciences $34.51 million 0.70 -$11.14 million ($0.53) -2.32
Betterware de Mexico SAPI de C $744.00 million 0.90 $55.37 million $1.95 8.74

Betterware de Mexico SAPI de C has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares BioHarvest Sciences and Betterware de Mexico SAPI de C’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BioHarvest Sciences -34.67% -55.88% -26.59%
Betterware de Mexico SAPI de C 8.08% 70.20% 10.82%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for BioHarvest Sciences and Betterware de Mexico SAPI de C, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioHarvest Sciences 1 0 2 0 2.33
Betterware de Mexico SAPI de C 1 0 1 1 2.67

BioHarvest Sciences presently has a consensus target price of $6.50, indicating a potential upside of 428.46%. Given BioHarvest Sciences’ higher probable upside, analysts plainly believe BioHarvest Sciences is more favorable than Betterware de Mexico SAPI de C.

Volatility & Risk

BioHarvest Sciences has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Betterware de Mexico SAPI de C has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500.

Summary

Betterware de Mexico SAPI de C beats BioHarvest Sciences on 12 of the 14 factors compared between the two stocks.

About BioHarvest Sciences

(Get Free Report)

BioHarvest Sciences Inc. is a biotechnology company that develops plant-based ingredients and consumer products using its proprietary Botanical Synthesis platform. The technology grows selected plant cells in controlled bioreactors, offering an alternative to cultivating and processing whole plants. The company’s best-known product is VINIA, a dietary supplement made from red grape cells. BioHarvest also works to develop additional botanical ingredients and products for consumer markets, including nutraceuticals and cosmetics.

About Betterware de Mexico SAPI de C

(Get Free Report)

Betterware de México, S.A.P.I. de C.V. is a consumer products company that sells household and personal-care products through a direct-selling network. Its Betterware brand focuses on practical products for home organization, storage, kitchen use, cleaning and other everyday needs, which are marketed through independent distributors and company sales channels. The company’s Mexican operations date to 1995. In 2022, Betterware acquired JAFRA, adding a beauty and personal-care business whose products include cosmetics, fragrances and skin-care items, sold through a network of consultants.

Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.